---
$id: https://graph.org.ai/products/commodity/51161721
$type: Product
source: UNSPSC
code: "51161721"
title: "Sivelestat"
class: "51161700"
classTitle: "Drugs used for respiratory tract disorders"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sivelestat

**UNSPSC Code**: 51161721
**Class**: [Drugs used for respiratory tract disorders](Drugs used for respiratory tract disorders.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor with the molecular formula C20H22N2O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DWI62G0P59, chemically known as o-(p-hydroxybenzenesulfonamido)hippuric acid, pivalate (ester) but generally known as sivelestat, which bears US NIH Compound Identifier 107706. European Medicines Agency schedules Sivelestat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10543MIG. The term SIVELESTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). Most nations schedule sivelestat under HS 29350090 and SITC 51580. As of Q4 2014, SIVELESTAT remains the US FDA Preferred Term for this commodity. Sivelestat bears US NLM identifiers UMLS ID C0130137 and NCI Concept Code C66539. SMILES: S(=O)(=O)(NC1C(CCCC1)C(=O)NCC(=O)O)C1CCC(OC(=O)C(C)(C)C)CC1.

